NEW YORK, August 5, 2026 – MetLife, Inc. (NYSE: MET) today announced that its board of directors has approved a new $3 billion authorization for the company to repurchase its common stock. The new authorization is incremental to the approximately $400 million remaining under the company’s prior authorization announced in April 2025.

“This new share repurchase authorization reflects our confidence in MetLife’s long-term outlook and continued ability to generate capital,” said MetLife President and Chief Executive Officer Michel Khalaf. “Our diversified business portfolio, financial strength and disciplined execution continue to support durable growth and attractive returns. Consistent with our New Frontier strategy, we remain committed to deploying capital where it creates the greatest long-term value for shareholders.”

About MetLife

MetLife, Inc. (NYSE: MET), through its subsidiaries and affiliates (“MetLife”), is one of the world’s leading financial services companies, providing insurance, annuities, employee benefits and asset management to help individual and institutional customers build a more confident future. Founded in 1868, MetLife has operations in more than 40 markets globally and holds leading positions in the United States, Asia, Latin America, Europe and the Middle East. For more information, visit www.metlife.com.

Forward-Looking Statements

The forward-looking statements in this news release, using words such as “confidence,” “continue,” “durable,” “long-term,” and “remain” are based on assumptions and expectations that involve risks and uncertainties, including the “Risk Factors” MetLife, Inc. describes in its U.S. Securities and Exchange Commission filings. MetLife’s future results could differ, and it does not undertake any obligation to publicly correct or update any of these statements.